MARATTO

article · International Journal of Immunology

Assessment of Inflammatory Markers in Children with Lymphadenopathy

2026Open accessTanta University

Abstract

Lymphadenopathy is palpable enlargement of lymph nodes. Inflammation is a normal part of your body's response to injuries and invaders. It promotes healing and helps you feel better.Inflammation is a vital biological mechanism that acts as the body's primary defense against harmful agents, such as pathogens, damaged cells, and irritants. Although acute inflammation is important for healing and recovery, chronic inflammation may result in various diseases, including cancer, cardiovascular issues, and autoimmune disorders. Inflammation can arise from numerous causes of lymphadenopathy, including microbial infections, autoimmune diseases, cancers, and other factors that contribute to elevated inflammatory markers in the bloodstream. Inflammatory markers as Erythrocyte sedimentation rate (ESR) and C Reactive Protein (CRP) were measured in serum of children with lymphadenopathy to help for monitoring the inflammation state. The erythrocyte sedimentation rate and C-reactive protein are among the oldest laboratory tests still in use. The results Showed that, there was significant increase in Erythrocyte sedimentation rate in first and second hour in children with lymphadenopathy compared to healthy control children (P value = 0.001) (P value = 0.001) respectively. There was also significant increase in serum level of C Reactive Protein in children with lymphadenopathy compared to healthy control children (P value = 0.007).

Research topics

  • Lymphadenopathy Diagnosis and Analysis
  • Inflammatory Biomarkers in Disease Prognosis
  • Hematological disorders and diagnostics

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.11648/j.iji.20261401.14

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.